• Transmedics Group Inc TMDX.OQ reported quarterly adjusted earnings of $2.62​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 19 cents. The mean expectation of twelve analysts for the quarter was for earnings of 39 cents per share. Wall Street expected results to range from 22 cents to 62 cents per share.

• Revenue rose 18.3% to $160.76 million from a year ago; analysts expected $155.72 million.

• Transmedics Group Inc's reported EPS for the quarter was 66 cents​.

• The company reported quarterly net income of $24.32 million.

• Transmedics Group Inc shares had risen by 10.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.2% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Transmedics Group Inc is $149.00, about 7.5% above its last closing price of $137.78

This summary was machine generated from LSEG data February 24 at 10:42 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)